It is established that TNF‐α, IL‐6, and IL‐1β are key proinflammatory cytokines involved in the onset of colitis,27 and IL‐10, an anti‐inflammatory cytokine, increases following Res administration in IBD patients.28 This evidence concerns the gene TNF and colitis.